VEGFA and neoplasm: In addition to showing application prospects in neovascular age-related macular degeneration, this strategy is also applicable to VEGF/Ang2-driven abnormal tumor vascular remodeling and immunosuppression, and is expected to improve the tumor immune microenvironment, enhance immune cell infiltration, and enhance anti-tumor effects [45].